United States
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 59.35 T
|
Sept. 30, 2024 | USD 2.06 | 1.98% |
|
United States |
|
2 |
USD 93.90 B
|
Dec. 31, 2023 | USD 56.48 | -0.60% |
|
United States |
|
3 |
USD 89.42 B
|
Dec. 31, 2023 | USD 26.52 | -1.45% |
|
United States |
|
4 |
USD 86.47 B
|
Dec. 31, 2023 | USD 183.90 | 4.70% |
|
United States |
|
5 |
USD 80.44 B
|
Dec. 31, 2023 | USD 542.49 | -0.56% |
|
United States |
|
6 |
USD 72.53 B
|
Dec. 31, 2023 | USD 285.42 | 0.49% |
|
United States |
|
7 |
USD 69.41 B
|
Jan. 31, 2024 | USD 98.16 | -0.50% |
|
United States |
|
8 |
USD 52.50 B
|
Dec. 31, 2023 | USD 152.15 | -0.47% |
|
United States |
|
9 |
USD 43.41 B
|
Dec. 31, 2023 | USD 58.95 | -0.32% |
|
United States |
|
10 |
USD 43.35 B
|
Dec. 31, 2023 | USD 98.82 | -0.13% |
|
United States |
|
11 |
USD 42.50 B
|
Dec. 31, 2023 | USD 329.91 | -1.41% |
|
United States |
|
12 |
USD 41.90 B
|
Aug. 31, 2024 | USD 10.28 | -10.30% |
|
United States |
|
13 |
USD 37.87 B
|
Dec. 31, 2023 | USD 597.75 | -1.48% |
|
United States |
|
14 |
USD 28.10 B
|
Dec. 31, 2023 | USD 97.20 | 0.26% |
|
United States |
|
15 |
USD 27.73 B
|
Dec. 31, 2023 | USD 395.70 | -0.91% |
|
United States |
|
16 |
USD 25.85 B
|
Dec. 31, 2023 | USD 811.08 | -1.48% |
|
United States |
|
17 |
USD 23.23 B
|
Dec. 31, 2023 | USD 64.03 | -0.91% |
|
United States |
|
18 |
USD 22.85 B
|
Feb. 3, 2024 | USD 61.64 | 0.98% |
|
United States |
|
19 |
USD 22.72 B
|
Dec. 31, 2023 | USD 222.74 | -0.15% |
|
United States |
|
20 |
USD 22.44 B
|
Sept. 30, 2024 | USD 247.60 | -0.36% |
|
United States |
|
21 |
USD 20.55 B
|
Dec. 31, 2023 | USD 127.93 | -0.68% |
|
United States |
|
22 |
USD 19.44 B
|
Dec. 31, 2023 | USD 11.28 | -1.23% |
|
United States |
|
23 |
USD 18.04 B
|
Dec. 31, 2023 | USD 140.89 | -1.63% |
|
United States |
|
24 |
USD 16.68 B
|
March 31, 2024 | USD 594.75 | -1.63% |
|
United States |
|
25 |
USD 16.16 B
|
Dec. 31, 2023 | USD 88.30 | -1.40% |
|
United States |
|
26 |
USD 16.02 B
|
Feb. 24, 2024 | USD 20.05 | NA |
|
United States |
|
27 |
USD 14.08 B
|
Dec. 31, 2023 | USD 201.36 | -0.21% |
|
United States |
|
28 |
USD 13.40 B
|
Dec. 31, 2023 | USD 391.29 | 0.22% |
|
United States |
|
29 |
USD 13.30 B
|
Dec. 31, 2023 | USD 32.56 | -1.63% |
|
United States |
|
30 |
USD 13.14 B
|
Dec. 31, 2023 | USD 3.20 | -2.44% |
|
United States |
|
31 |
USD 12.69 B
|
June 30, 2024 | USD 123.66 | -3.59% |
|
United States |
|
32 |
USD 12.23 B
|
Dec. 31, 2023 | USD 176.20 | -0.17% |
|
United States |
|
33 |
USD 12.04 B
|
Sept. 30, 2024 | USD 254.21 | -1.64% |
|
United States |
|
34 |
USD 11.88 B
|
Dec. 31, 2023 | USD 293.23 | -1.24% |
|
United States |
|
35 |
USD 10.67 B
|
Dec. 31, 2023 | USD 102.36 | -0.66% |
|
United States |
|
36 |
USD 9.21 B
|
Dec. 31, 2023 | USD 15.56 | -2.57% |
|
United States |
|
37 |
USD 9.20 B
|
Dec. 31, 2023 | USD 74.06 | -1.65% |
|
United States |
|
38 |
USD 8.61 B
|
Dec. 31, 2023 | USD 143.93 | -1.57% |
|
United States |
|
39 |
USD 7.76 B
|
Dec. 31, 2023 | USD 575.65 | 0.89% |
|
United States |
|
40 |
USD 6.24 B
|
Dec. 31, 2023 | USD 22.28 | 0.27% |
|
United States |
|
41 |
USD 6.15 B
|
Dec. 31, 2023 | USD 109.48 | -1.03% |
|
United States |
|
42 |
USD 6.14 B
|
Dec. 31, 2023 | USD 31.58 | -0.03% |
|
United States |
|
43 |
USD 5.80 B
|
Feb. 3, 2024 | USD 37.61 | -1.98% |
|
United States |
|
44 |
USD 5.79 B
|
Dec. 31, 2023 | USD 163.10 | -0.65% |
|
United States |
|
45 |
USD 5.75 B
|
Dec. 31, 2023 | USD 188.56 | -0.39% |
|
United States |
|
46 |
USD 5.61 B
|
Dec. 31, 2023 | USD 249.80 | -0.69% |
|
United States |
|
47 |
USD 4.87 B
|
Dec. 31, 2023 | USD 19.67 | -0.81% |
|
United States |
|
48 |
USD 4.80 B
|
Dec. 31, 2023 | USD 81.33 | -0.37% |
|
United States |
|
49 |
USD 4.57 B
|
Dec. 31, 2023 | USD 4.63 | -2.53% |
|
United States |
|
50 |
USD 4.24 B
|
Dec. 31, 2023 | USD 126.13 | -0.56% |
|
United States |
The Healthcare company in United States with the highest Total Non-Current Liabilities is Outlook Therapeutics, Inc. (NasdaqCM: OTLK) at USD 59.35 T.
The Healthcare company in United States with the lowest Total Non-Current Liabilities is Protagonist Therapeutics, Inc. (NasdaqGM: PTGX) at USD 0.00.
The top 10 Healthcare companies in United States by Total Non-Current Liabilities are Outlook Therapeutics, Inc., CVS Health Corporation, Pfizer Inc., AbbVie Inc., UnitedHealth Group Incorporated, Amgen Inc., Walmart Inc., Johnson & Johnson, Bristol-Myers Squibb Company and Merck & Co., Inc..
The bottom 10 Healthcare companies in United States by Total Non-Current Liabilities are Protagonist Therapeutics, Inc., Eton Pharmaceuticals, Inc., ARS Pharmaceuticals, Inc., Semler Scientific, Inc., Nutriband Inc., Pasithea Therapeutics Corp., NeuroMetrix, Inc., Intelligent Bio Solutions Inc., Palisade Bio, Inc. and LungLife AI, Inc..